Clinical trial
Analysis of the Prognostic Role of Epigenetic Biomarkers in Relation to the Motor Decline in Parkinson's Disease
NCT05384522 is registered in ClinicalTrials.gov with Istituto Nazionale di Ricovero e Cura per Anziani as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Analysis of the Prognostic Role of Epigenetic Biomarkers in Relation to the Motor Decline in Parkinson's Disease
- Lead sponsor
- Istituto Nazionale di Ricovero e Cura per Anziani
- Phase
- Observational
- Overall status
- Unknown status
- Start date
- May 30, 2024
- Completion date
- January 30, 2026
- Enrollment
- 103 (estimated)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.